Traumatic Brain Injury with Conflicting Coagulopathy and Antithrombotic Reversal
A 71-year-old man on apixaban 5 mg BID for atrial fibrillation and aspirin 81 mg daily falls down stairs and presents with a GCS of 13 (E3 V4 M6) that drops to 9 at 45 minutes. CT shows a 12 mm right frontal acute subdural hematoma with 6 mm midline shift, a left frontal contusion, and a small traumatic subarachnoid hemorrhage. He is intubated and taken for emergent craniotomy. Pre-op labs: INR 1.4, aPTT 32, platelets 140,000, creatinine 1.2, Hb 11.2. Last apixaban dose was ~10 hours ago. The family reports he has a mechanical mitral valve (not just atrial fibrillation) and is on apixaban because of prior GI bleeding. He is 82 kg.
1. What reversal strategy do you choose for the apixaban and aspirin, and how does the mechanical mitral valve change the calculus?
Read the worked answer
Reversal: For life-threatening intracranial hemorrhage on a direct factor Xa inhibitor within ~10–15 h of the last dose, give andexanet alfa (per label dosing, low-dose for apixaban 5 mg BID: 400 mg bolus + 4 mg/min for 120 min) or 4-factor PCC 50 units/kg if andexanet is unavailable. The ANNEXA-4 data support andexanet; PCC is a reasonable alternative with lower cost and no thrombosis signal as strong, though evidence is weaker. Also give platelet transfusion for aspirin? - evidence (PATCH trial) does not support platelet transfusion in spontaneous ICH on antiplatelet therapy; for traumatic ICH the data are also not supportive, so do not routinely transfuse platelets unless there is a documented platelet function defect or ongoing bleeding. Check and correct fibrinogen and consider tranexamic acid (CRASH-3 supports TXA in mild-moderate TBI within 3 h).
Mechanical mitral valve: This is the key judgment. Reversing anticoagulation in a patient with a mechanical mitral valve carries a real risk of valve thrombosis and thromboembolism, but the immediate threat is exsanguinating intracranial hemorrhage and herniation - reversal is indicated. The plan should be: reverse now for surgery, then restart anticoagulation as soon as hemostasis is secure (typically 3–7 days, individualized with serial imaging), because the mechanical valve cannot go unprotected long-term. Coordinate with cardiology and CT surgery; if anticoagulation must be interrupted, consider bridging with unfractionated heparin once the risk of rebleeding is acceptable. Document the competing risks explicitly.
2. What is the evidence-based BP and osmotherapy approach in the operating room and immediately post-op, and how do you monitor for delayed deterioration?
Read the worked answer
BP: In acute TBI with a surgical hematoma, the priority is CPP (goal 60–70 mmHg) and avoidance of hypotension (systolic <90–100 is associated with doubled mortality - the "EBIC" and Brain Trauma Foundation data). There is no strong evidence for a specific upper BP target in traumatic SDH; treat hypertension that risks expansion (e.g., SBP >160–180) cautiously while preserving CPP. Avoid nitroprusside (ICP rise, cyanide); use nicardipine or clevidipine, or labetalol/esmolol if no contraindication. In the OR, maintain MAP to keep CPP ≥60–70, avoid hypotension during induction (use hemodynamically neutral agents, fluid bolus, vasopressors ready).
Osmotherapy: If ICP rises or herniation signs appear, give hypertonic saline (e.g., 3% 250 mL bolus or 23.4% 30 mL via central line) or mannitol 0.5–1 g/kg - both are acceptable; hypertonic saline may be preferred with hypotension (mannitol causes osmotic diuresis and transient hypotension). Monitor Na/osmolality (ceiling ~155–160 and osmolality ~320). Do not give steroids (CRASH trial showed harm).
Monitoring for delayed deterioration: serial neuro exams when sedation allows, ICP monitor (parenchymal or EVD) if indicated (GCS ≤8 with abnormal CT), repeat CT for any change or routinely at 6–24 h post-op, pupillometry, continuous EEG if unexplained coma or to detect nonconvulsive seizures, and coagulation labs (INR, aPTT, fibrinogen, platelet function) every 6–12 h initially. Watch for contusion expansion, delayed epidural/subdural reaccumulation, and hydrocephalus. Maintain normothermia, normoglycemia, and seizure prophylaxis for 7 days (levetiracetam), then discontinue if no seizures.